Amicus Therapeutics Target Price

Amicus Therapeutics target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$14.49

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-01-22	JefferiesDennis Ding	$14.5	0.1% upside
2025-12-19	Cantor Fitzgerald	$14.5	0.1% upside
2025-09-18	Needham	$14	3.4% downside
2024-10-17	Bank of America SecuritiesTazeen Ahmad	$15	3.5% upside
2024-05-14	GuggenheimDebjit Chattopadhyay	$13	10.3% downside
2024-05-09	Morgan StanleyJeffrey Hung	$19	31.1% upside
2023-12-19	Morgan StanleyJeffrey Hung	$20	38% upside
2021-05-10	Goldman SachsSalveen Richter	$14	3.4% downside

Amicus Therapeutics (FOLD) FAQ

Stockcircle tracks target price for Amicus Therapeutics (FOLD), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Amicus Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main FOLD overview so you can move from this figure to the surrounding analysis quickly.